Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

@article{Murray2013DisabilityadjustedLY,
  title={Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010},
  author={Christopher J. L. Murray and Theo Vos and Rafael Lozano and Mohsen Naghavi and Abraham D. Flaxman and Catherine M. Michaud and Majid Ezzati and Kenji Shibuya and Joshua A. Salomon and Safa Abdalla and Victor Aboyans and Jerry Puthenpurakal Abraham and Ilana N. Ackerman and Rakesh Aggarwal and Stephanie Y Ahn and Mohammed K. Ali and Mohammad A. Almazroa and Miriam R. Alvarado and Hugh Ross Anderson and Laurie M. Anderson and Kathryn G Andrews and Charles Atkinson and Larry M. Baddour and Adil N. Bahalim and Suzanne Lyn Barker-Collo and Lope H. Barrero and David H Bartels and Mar{\'i}a-Gloria Bas{\'a}{\~n}ez and Amanda J. Baxter and Michelle L. Bell and Emelia J. Benjamin and Derrick A Bennett and Eduardo Bernab{\'e} and Kavi Bhalla and Bishal Bhandari and Boris Bikbov and Aref A. Bin. Abdulhak and Gretchen L. Birbeck and James A Black and Hannah Blencowe and Jed D. Blore and Fiona M Blyth and Ian Bolliger and Audrey Bonaventure and Soufiane Boufous and Rupert R A Bourne and Michel Boussinesq and Tasanee Braithwaite and Carol Brayne and Lisa A Bridgett and Simon J. Brooker and Peter M Brooks and Traolach Brugha and Claire Bryan-Hancock and Chiara Bucello and Rachelle Buchbinder and Geoffrey C. Buckle and Christine M Budke and Michael Burch and Peter G. J. Burney and Roy Burstein and Bianca Calabria and Benjamin Campbell and Charles E. Canter and H{\'e}l{\`e}ne Carabin and Jonathan R Carapetis and Loreto Carmona and Claudia Cella and Fiona Charlson and Honglei Chen and Andrew Tai-Ann Cheng and David P Chou and Sumeet S. Chugh and Luc E. Coffeng and Steven D. Colan and Samantha M. Colquhoun and Katherine Ellicott Colson and Jean Condon and Myles Dean Connor and Leslie Cooper and Matthew A. Corriere and Monica Cortinovis and Karen Courville de Vaccaro and William G. Couser and Benjamin C Cowie and Michael H. Criqui and Marita Cross and Kaustubh C Dabhadkar and Manu Dahiya and Nabila Dahodwala and James Damsere-Derry and Goodarz Danaei and Adrian Davis and Diego De Leo and Louisa Degenhardt and Robert P. Dellavalle and Allyne Delossantos and Julie O. Denenberg and Sarah Derrett and Don Des Jarlais and Samath Dhamminda Dharmaratne and Mukesh Dherani and C{\'e}sar D{\'i}az-Torn{\'e} and Helen Dolk and Earl Ray Dorsey and Tim R Driscoll and Herbert C Duber and Beth H. Ebel and Karen Margaret Edmond and Alexis Elbaz and Suad Eltahir Ali and Holly E. Erskine and Patricia J. Erwin and Patricia Espindola and Stalin E Ewoigbokhan and Farshad Farzadfar and Valery L. Feigin and David T. Felson and Alize J. Ferrari and Cleusa Pinheiro Ferri and Eric M. F{\`e}vre and Mariel McKenzie Finucane and Seth Flaxman and Louise Flood and Kyle Foreman and Mohammad Hossein Forouzanfar and Francis Gerry R Fowkes and Marlene Fransen and Michael K Freeman and Belinda J. Gabbe and Sherine E. Gabriel and Emmanuela Gakidou and Hammad Ashraf Ganatra and Bianca Garcia and Flavio Gaspari and Richard Frank Gillum and Gerhard Gmel and Diego Gonz{\'a}lez-Medina and Richard Gosselin and Rebecca Grainger and Bridget F. Grant and Justina Groeger and Francis Guillemin and David Gunnell and Ramyani P Gupta and Juanita A. Haagsma and Holly Hagan and Yara A. Halasa and Wayne D Hall and Diana Haring and Josep Maria Haro and James E. Harrison and Rasmus J Havmoeller and Roderick Hay and Hideki Higashi and Catherine L. Hill and Bruno Hoen and Howard J Hoffman and Peter Jay Hotez and Damian G Hoy and John J Emmanuel Huang and Sydney E. Ibeanusi and Kathryn H. Jacobsen and Spencer L James and Deborah L. Jarvis and Rashmi Jasrasaria and Sudha Jayaraman and Nicole E Johns and Jost B. Jonas and Ganesan Karthikeyan and Nicholas J Kassebaum and Norito Kawakami and Andre Keren and Jon Paul Khoo and Charles H. King and Lisa M. Knowlton and Olive Kobusingye and Adofo Koranteng and Rita Krishnamurthi and Francine Laden and Ratilal Lalloo and Laura L. Laslett and Timothy J H Lathlean and Janet L Leasher and Yong Yi Lee and James Leigh and Daphna Levinson and Stephen S. Lim and Elizabeth S Limb and John Kent Lin and Michael S. Lipnick and Steven E. Lipshultz and Wei Liu and Maria Loane and Summer Lockett Ohno and Ronan A. Lyons and Jacqueline R. Mabweijano and Michael F Macintyre and Reza Malekzadeh and Leslie Mallinger and Sivabalan Manivannan and Wagner Marcenes and Lyn March and David J. Margolis and Guy B. Marks and Robert G. Marks and Akira Matsumori and Richard G Matzopoulos and Bongani M. Mayosi and John H. Mcanulty and Mary M. McDermott and Neil McGill and John Mcgrath and Mar{\'i}a Elena Medina-Mora and Michele Meltzer and Ziad A. Memish and George A. Mensah and Tony Raymond Merriman and Ana-Claire L. Meyer and Valeria Miglioli and Matthew Miller and Ted R Miller and Philip B. Mitchell and Charles N. Mock and Ana Olga Mocumbi and Terrie E. Moffitt and Ali A Mokdad and Lorenzo Monasta and Marcella Montico and Maziar Moradi-Lakeh and Andrew E. Moran and Lidia Morawska and Rintaro Mori and Michele E Murdoch and Michael K Mwaniki and Kovin Naidoo and M. Nathan Nair and Luigi Naldi and K. M. Venkat Narayan and Paul K. Nelson and Robert G Nelson and Michael C. Nevitt and Charles R. Newton and Sandra Nolte and Paul Norman and Rosana E Norman and Martin O'Donnell and Simon J O'Hanlon and Casey Olives and Saad B. Omer and Katrina F. Ortblad and Richard Osborne and Doruk E. Ozgediz and Andrew Page and Bishnu Pahari and Jeyaraj Durai Pandian and Andrea Panozo Rivero and Scott B. Patten and Neil Pearce and Rogelio P{\'e}rez Padilla and Fernando Perez-Ruiz and Norberto Perico and Konrad Pesudovs and David E Phillips and Michael R Phillips and Kelsey Pierce and S{\'e}bastien D S Pion and Guilherme Vanoni Polanczyk and Suzanne Polinder and C. Arden Pope and Svetlana Popova and Esteban Porrini and Farshad Pourmalek and Martin Prince and Rachel L. Pullan and Kapa D. Ramaiah and Dharani Ranganathan and Homie Razavi and Mathilda Regan and J{\"u}rgen Rehm and David B. Rein and Guiseppe Remuzzi and Kathryn Richardson and Frederick P. Rivara and Thomas J Roberts and Carol V. Robinson and Felipe Rodriguez De Le{\'o}n and Luca Ronfani and Robin Room and Lisa C Rosenfeld and Lesley Rushton and Ralph L. Sacco and Sukanta Saha and Uchechukwu Sampson and L{\'i}dia S{\`a}nchez-Riera and Ella Sanman and David C. Schwebel and James G. Scott and Mar{\'i}a Segu{\'i}-G{\'o}mez and Saeid Shahraz and Donald S. Shepard and Hwashin Hyun Shin and Rupak Shivakoti and Donald Silberberg and David Singh and Gitanjali M Singh and Jasvinder A. Singh and Jessica Singleton and David A. Sleet and Karen Sliwa and Emma Smith and Jennifer L Smith and Nicolas J C Stapelberg and Andrew Steer and Timothy J. Steiner and Wilma A. Stolk and Lars Stovner and Christopher R Sudfeld and Sana Syed and Giorgio Tamburlini and Mohammad Tavakkoli and Hugh R Taylor and Jennifer A. Taylor and William John Taylor and Bernadette A. Thomas and W Murray Thomson and George D Thurston and Imad M. Tleyjeh and Marcello Tonelli and Jeffrey A. Towbin and T Truelsen and Miltiadis K Tsilimbaris and Clotilde Ubeda and Eduardo A. Undurraga and Marieke van der Werf and Jim van Os and Monica S Vavilala and Narayanaswamy Venketasubramanian and Mengru Wang and Wenzhi Wang and Kerrianne Watt and David J. Weatherall and Martin A Weinstock and Robert Weintraub and Marc G. Weisskopf and Myrna M. Weissman and Richard A. White and Harvey A. Whiteford and Natasha Wiebe and Steven T. Wiersma and James D. Wilkinson and Hywel C. Williams and Sean R. Williams and Emma Witt and Frederick Wolfe and Anthony D. Woolf and Sarah K Wulf and Pon-Hsiu Yeh and Anita K. M. Zaidi and Zhi-Jie Zheng and David Zonies and Alan D. Lopez},
  journal={The Lancet},
  year={2013},
  volume={380},
  pages={2197-2223}
}
BACKGROUND Measuring disease and injury burden in populations requires a composite metric that captures both premature mortality and the prevalence and severity of ill-health. [...] Key Method DALYs were calculated for 291 causes, 20 age groups, both sexes, and for 187 countries, and aggregated to regional and global estimates of disease burden for three points in time with strictly comparable definitions and methods.Expand

Paper Mentions

Observational Clinical Trial
In this project, the investigators will study a cohort of preterm infants, together with their parents, during NICU hospitalization and follow their developmental trajectory until… Expand
ConditionsPremature Birth of Newborn
Interventional Clinical Trial
The overall objective of this study is to develop a feasible and acceptable mental health app which delivers Cognitive Behavioral Therapy (CBT) for depressed patients in the Dominican… Expand
ConditionsDepression Mild, Depression Moderate
InterventionBehavioral
Interventional Clinical Trial
This study will be an open-label trial to determine the functional effects of bilateral IA injections of Zilretta into knee joints of 70 subjects with bilateral KL grade 2-4… Expand
ConditionsKnee Osteoarthritis
InterventionDrug
Interventional Clinical Trial
The study design was randomized control trial and sampling technique was lottery method. After inclusion and exclusion criteria, sample populations were divided into experimental… Expand
ConditionsRadiculopathy Lumbar
InterventionOther
Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
TLDR
At a global level, DALYs and HALE continue to show improvements and the importance of continued health interventions, which has changed in most locations in pace with the gross domestic product per person, education, and family planning. Expand
Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
TLDR
DALYs and HALE and their relationship to SDI represents a robust framework on which to benchmark geography-specific health performance and SDG progress and supports continued efforts to elevate personal income, improve education, and limit fertility. Expand
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition
TLDR
Patterns of the epidemiological transition with a composite indicator of sociodemographic status, which was constructed from income per person, average years of schooling after age 15 years, and the total fertility rate and mean age of the population, were quantified. Expand
The global burden of injury: incidence, mortality, disability-adjusted life years and time trends from the Global Burden of Disease study 2013
TLDR
An overview of injury estimates from the 2013 update of GBD is provided, with detailed information on incidence, mortality, DALYs and rates of change from 1990 to 2013 for 26 causes of injury, globally, by region and by country. Expand
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010
TLDR
The findings show the striking and growing challenge that these disorders pose for health systems in developed and developing regions. Expand
Disability-Adjusted Life Years (DALYs) for Injuries Using Death Certificates and Hospital Discharge Survey by the Korean Burden of Disease Study 2012
TLDR
This study estimated national burdens of injuries in Korea using more reliable data and disability weightings to contribute to the reliable evaluation of injury burden and a better understanding of injury-related health status using nation-specific, dependable data. Expand
Disability-Adjusted Life-Years (DALYs) for 315 Diseases and Injuries and Healthy Life Expectancy (HALE) in Iran and its Neighboring Countries, 1990-2015: Findings from Global Burden of Disease Study 2015.
TLDR
The levels and trends in causes of DALYs, life expectancy, and HALE generally show similarities between the 16 countries, although differences exist; the pattern of change is similar in almost all 16 countries. Expand
Global and regional burden of death and disability from peripheral artery disease: 21 world regions, 1990 to 2010.
A comprehensive and systematic assessment of disability and mortality due to lower extremity peripheral artery disease (PAD) is lacking. Therefore, we estimated PAD deaths, disability-adjusted lifeExpand
Calculating disability-adjusted life years to quantify burden of disease
TLDR
The disability-adjusted life year’s basic features are summarized and an ‘‘Appendix’’ includes R code to calculate DALYs. Expand
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
TLDR
This work estimated deaths and disability-adjusted life years (DALYs) attributable to the independent effects of 67 risk factors and clusters of risk factors for 21 regions in 1990 and 2010 and calculated the burden attributable to each risk factor exposure compared with the theoretical-minimum-risk exposure. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 119 REFERENCES
Measuring the burden of disease and injury in Spain using disability-adjusted life years: an updated and policy-oriented overview.
TLDR
Measuring DALYs specifically for Spain represents a systematic analysis of population health losses, and also provides an important measure to track the outcomes of future health interventions. Expand
A national burden of disease calculation: Dutch disability-adjusted life-years. Dutch Burden of Disease Group.
TLDR
The DALY approach appeared to be feasible at a national Western European level and produced interpretable results, comparable to results from the Global Burden of Disease Study for the Established Market Economies. Expand
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
TLDR
Prevalence and severity of health loss were weakly correlated and age-specific prevalence of YLDs increased with age in all regions and has decreased slightly from 1990 to 2010, but population growth and ageing have increased YLD numbers and crude rates over the past two decades. Expand
Assessing the burden of disease and injury in Los Angeles County using disability-adjusted life years.
TLDR
The DALYs measure is a promising new tool to improve the capacity of local health departments and other health agencies to assess population health and establish an evidence base for public health decisions. Expand
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010
TLDR
This study represents the most extensive empirical effort as yet to measure disability weights and reports strong evidence of highly consistent results. Expand
Measuring burden of disease in two inner London boroughs using Disability Adjusted Life Years.
TLDR
A pragmatic approach is used to estimate overall disease burden providing a local, more comprehensive picture with important differences in spend by disease and health authority area, however, a more detailed approach to support decisions about prioritization based on modelling interventions that impact on avoidable burden of disease is recommended. Expand
Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: Global Burden of Disease Study
TLDR
The higher proportion of lifespan spent disabled in high-mortality populations is consistent with the compression of morbidity hypothesis and the threshold definition of disability used substantially affects the results of DFLE, DALE, which incorporates severity weights for disabilities, is a useful summary measure of the burden of disability and mortality. Expand
Assessing the burden of disease in the United States using disability-adjusted life years.
TLDR
This analysis provides the first detailed, comprehensive estimates using DALYs of the fatal and nonfatal conditions that exact large health burdens in the United States. Expand
Singapore's burden of disease and injury 2004.
TLDR
This study provides an objective and systematic assessment of the fatal and nonfatal health conditions in Singapore to support priority setting in public health policies and research. Expand
Estimating the burden of disease in one Swiss canton: what do disability adjusted life years (DALY) tell us?
TLDR
Some of the most important problems identified-depression, osteoarthritis and alcohol abuse-would have been overlooked in an analysis based solely on mortality data, and the most striking finding is the importance of mental health problems. Expand
...
1
2
3
4
5
...